250,95 €
0,20 % gestern
L&S, 30. Oktober, 22:55 Uhr
ISIN
US0311621009
Symbol
AMGN
Berichte

Amgen Aktie News

Neutral
PRNewsWire
ein Tag alt
THOUSAND OAKS, Calif. , Oct. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2025 financial results on Tuesday, November 4, 2025, after the close of the U.S. financial markets.
Positiv
The Motley Fool
7 Tage alt
Amgen faced some patent cliffs this year, but its financial results remain strong. It is developing newer medicines that should help it move beyond this challenge.
Positiv
Market Watch
8 Tage alt
Slow and steady performers do better over the long term.
Neutral
Business Wire
8 Tage alt
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amgen Inc. (NASDAQ: AMGN) breached their fiduciary duties to shareholders. If you currently own Amgen stock and acquired shares on or before July 29, 2020, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-appro...
Positiv
24/7 Wall Street
10 Tage alt
What's the first thing that springs to mind when someone mentions the Nasdaq Composite?
Positiv
Reuters
13 Tage alt
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic sinus infection, the drugmakers said on Friday.
Neutral
PRNewsWire
13 Tage alt
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif. , Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with na...
Positiv
CNBC
23 Tage alt
Amgen is the latest drugmaker to sell certain drugs directly to consumers amid pressure from President Donald Trump. Meanwhile, Dr. Oz talks GLP-1s for obesity.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen